CDXS(Codexis, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $104.75M | $138.59M | $70.14M | $59.34M | $70.39M |
| 毛利润 | $82.55M | $100.56M | $57.33M | $43.06M | $61.05M |
| 营业利润 | −$22.70M | −$34.88M | −$68.07M | −$58.52M | −$41.74M |
| 净利润 | −$21.28M | −$33.59M | −$76.24M | −$65.28M | −$43.97M |
| 经营现金流 | −$14.27M | $11.28M | −$52.64M | −$49.41M | −$19.38M |
| 自由现金流 | −$28.09M | $2.98M | −$57.06M | −$53.72M | −$23.85M |
| 摊薄每股收益 | $-0.33 | $-0.51 | $-1.12 | $-0.89 | $-0.50 |